CS
MBOT icon

Credit Suisse’s Microbot Medical MBOT Stock Holding History

Credit Suisse’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10
Closed -$20K – 4668
2014
Q3 		$20K Hold
10
– – ﹤0.01% 4395
2014
Q2 		$32K Hold
10
– – ﹤0.01% 4615
2014
Q1 		$21K Sell
10
-3
-23% -$7.17K ﹤0.01% 4616
2013
Q4 		$25K Buy
+13
New +$27.5K ﹤0.01% 4554
2013
Q3 		– Sell
-9
Closed -$25K – 4305
2013
Q2 		$25K Buy
+9
New +$25.4K ﹤0.01% 4138

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Credit Suisse's MBOT Position: Q4 2014 in Review

Credit Suisse sold out of Microbot Medical (MBOT) in Q4 2014, closing a stake of 10 shares — an estimated $20K sold.

Credit Suisse first reported a position in MBOT in Q2 2013 and held it in 5 quarters. The position peaked at $32K in Q2 2014. 40 funds tracked by Wall St. Rank hold MBOT as of Q4 2014.

  • Credit Suisse reported no remaining Microbot Medical position as of Q4 2014 after selling out during the quarter.
  • Credit Suisse sold 10 Microbot Medical shares in Q4 2014, an estimated $20K.
  • Credit Suisse first reported a position in Microbot Medical in Q2 2013 and held it in 5 quarters.
  • Credit Suisse's Microbot Medical position peaked at $32K in Q2 2014.
  • 40 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2014.

Based on Credit Suisse's 13F filing for Q4 2014, filed 13 Feb 2015.